Psychedelic Microdosing - Just a Placebo Effect?

Authors: Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J. Nutt, Robin L. Carhart-Harris, David Erritzoe Published: March 2, 2021 What is microdosing? Psychedelic microdosing involves consuming psychedelics such as LSD or psilocybin mushrooms at a microdose, which is typically about 10% of a recreational dose. Microdosing is gaining increasing popularity, with  …

2020 - The Year Of The Mushroom

By Dr Hannah Thurgur an Honorary Research Assistant for Drug Science As we welcome in the new year, Drug Science reflects on the year of 2020 for psilocybin research and celebrates these achievements. Here we focus on the use of psilocybin-assisted therapy in three different conditions to reflect the breadth of research currently taking place  …


Women in Psychedelic Science - Part 2

This is the second Women in Psychedelic Science symposium to showcase the ground-breaking and outstanding work of women in psychedelics. The symposium provides a clinical perspective of psychedelic therapy, as well as developments in psychedelic fieldwork.   Psychedelic therapy – Clinical trials: Dr Sara Tai  A clinical psychologist and expert in psychotherapy in clinical trials  …


Study Drug Sessions - Insights on psychedelic microdosing

In July 2020, Drug Science launched the Medical Psychedelics Working Group (MPWG) – a consortium of experts, leading researchers and policy specialists. The overarching goal of this group is to create a rational and enlightened approach to psychedelic research and clinical treatment. To achieve this, education and destigmatisation will be critical in changing the public’s  …


Clinical Insights - MDMA for Alcohol Use Disorder

Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the preliminary data in an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed the full 8-week MDMA-assisted psychotherapy course,  …


Study Drug Sessions - Sex, sexuality and body image

In July 2020, Drug Science launched the Medical Psychedelics Working Group (MPWG) – a consortium of experts, leading researchers and policy specialists. The overarching goal of this group is to create a rational and enlightened approach to psychedelic research and clinical treatment. To achieve this, education and destigmatisation will be critical in changing the public’s  …